TEUCER DIAGNOSTICS, INC.
Podocyturia based assay as a predictive biomarker for systemic vascular diseases
Podocyturia based assay as a predictive biomarker for systemic vascular diseases is a funding opportunity from TEUCER DIAGNOSTICS, INC., up to 306101, closing March 31, 2027.
Mar 31, 2027
(243d left)Overview
PROJECT SUMMARY Cardiovascular disease (CVD) remains the leading cause of age-related morbidities and overall mortality worldwide. One of the major challenges in reducing the incidence of CVD is the difficulty in detecting its presence before clinical symptoms manifest, such as hypertension, chronic kidney disease…